Skip to main content

Table 1 Association between the expression of S100A4 and serum CA19.9 level and clinicopathological characteristics in PC n (%)

From: Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance

Clinicopathological parameter Cases (n) S100A4 expression P value Serum CA19.9 level P value
Positive (+) Negative (−) High (+) Normal (−)
Gender     0.917    0.489
 Male 75 56 (58.3) 19 (59.4)   68 (59.6) 7 (50.0)  
 Female 53 40 (41.7) 13 (40.6)   46 (40.4) 7 (50.0)  
Age (year)     0.355    0.203
 < 60 57 45 (46.9) 12 (37.5)   53 (46.5) 4 (28.6)  
 ≥ 60 71 51 (53.1) 20 (62.5)   61 (53.5) 10 (71.4)  
Tumor size (cm)     0.028    0.699
 ≤ 2 5 3 (3.1) 2 (6.3)   5 (4.4) 0  
 2–4 83 57 (59.4) 26 (81.3)   74 (64.9) 9 (64.3)  
 >4 40 36 (37.5) 4 (12.5)   35 (30.7) 5 (35.7)  
Tumor location     0.217    0.521
 Head 72 51 (53.1) 21 (65.6)   63 (55.3) 9 (64.3)  
 Body/tail 56 45 (46.9) 11 (34.4)   51 (44.7) 5 (35.7)  
Differentiation     0.007    0.000
 High 36 22 (22.9) 14 (43.8)   26 (22.8) 10 (71.4)  
 Middle 66 49 (51.0) 17 (53.1)   62 (54.4) 4 (28.6)  
 Low 26 25 (26.0) 1 (3.1)   26 (22.8) 0  
TNM stage     0.000    0.248
 I 11 6 (6.3) 5 (15.6)   10 (8.8) 1 (7.1)  
 II 47 26 (27.1) 21 (65.6)   39 (34.2) 8 (57.1)  
 III 52 46 (47.9) 6 (18.8)   47 (41.2) 5 (35.7)  
 IV 18 18 (18.8) 0   18 (15.8) 0  
Distant metastasis     0.076    0.194
 Present 26 23 (24.0) 3 (9.4)   25 (21.9) 1 (7.1)  
 Absent 102 73 (76.0) 29 (90.6)   89 (78.1) 13 (92.9)  
 Lymph node metastasis     0.025    0.003
 Present 66 55 (57.3) 11 (34.4)   64 (56.1) 2 (14.3)  
 Absent 62 41 (42.7) 21 (65.6)   50 (43.9) 12 (85.7)